fbpx

Bausch + Lomb and Clearside Biomedical Announce U.S. FDA Filing Acceptance for XIPERE

Bausch + Lomb, along with Clearside Biomedical, a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced that the U.S. Food and Drug Administration (FDA) has accepted the resubmitted New Drug Application for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension). FDA determined that the filing is a Class 2 resubmission and therefore assigned a Prescription Drug User Fee Act (PDUFA) action date of October 30, 2021. XIPERE is an investigational therapy with a proposed indication of treatment of macular edema associated with uveitis.

According to the company, Bausch + Lomb has the exclusive license for the commercialization and development of XIPERE in the United States and Canada.

“If approved by the FDA, XIPERE would be the first therapy available utilizing the suprachoroidal space for patients suffering from macular edema associated with uveitis, which is the leading cause of vision loss in people with uveitis,” said Yolande Barnard, vice president and general manager, U.S. Pharmaceuticals, Bausch + Lomb.

“XIPERE has the potential to advance the care of people suffering from macular edema with uveitis,” said George Lasezkay, Pharm.D., J.D., president and CEO, Clearside. “If approved, XIPERE would be our first commercial product and the first approved drug to be delivered into the suprachoroidal space (SCS®).”

XIPERE is designed for suprachoroidal administration via Clearside’s patented, proprietary SCS Microinjector® that offers unprecedented access to the back of the eye where sight-threatening disease often occurs.

Click HERE for the full press release.

Featured Posts

CooperVision

Innovative Sustainability Partnership Celebrates Far-Reaching Impacts on People + Planet

The multi-continent program—in collaboration with Plastic Bank®, eye care professionals, and contact lens wearers—has now prevented the equivalent of more than half a billion plastic bottles from entering the world’s oceans.

Learn More
CSI Dry eye software

CSI Dry Eye Software Announces Ken Barbet as New Chief Executive Officer

CSI Dry Eye Software, the first-of-its-kind dry eye management platform powered by artificial intelligence (AI), machine learning, and data science, announces the appointment of Ken Barbet as its new Chief Executive Officer (CEO).

Read more
Centre for Ocular Research & Education (CORE)

CORE Names Its “Top 10 of 2024” Scientific Papers

CORE reveals its Top 10 scientific papers of 2024, covering innovations in drug-releasing lenses, myopia control, scleral lenses for dry eye, and global contact lens trends. See the full list online.

Read more
March-April Optik 2025 Sustainability in Sight article

Sustainability in Sight: Green Frames, Lenses, and Best Practices

From Italy to Canada, discover the brands making sustainability more than a trend in eyewear—from renewable acetate to zero-waste contact lens programs.

Read more
Voila March-April Optik 2025 AYA CETANGI

Buffalo Spirit Meets Modern Vision: AYA Optical x Lakota Artist Yellowhawk

AYA Optical proudly introduces Cetangi, the latest eyewear style featuring Jim Yellowhawk’s White Buffalo design.

Read more
CooperVision

Innovative Sustainability Partnership Celebrates Far-Reaching Impacts on People + Planet

The multi-continent program—in collaboration with Plastic Bank®, eye care professionals, and contact lens wearers—has now prevented the equivalent of more than half a billion plastic bottles from entering the world’s oceans.

Learn More
CSI Dry eye software

CSI Dry Eye Software Announces Ken Barbet as New Chief Executive Officer

CSI Dry Eye Software, the first-of-its-kind dry eye management platform powered by artificial intelligence (AI), machine learning, and data science, announces the appointment of Ken Barbet as its new Chief Executive Officer (CEO).

Read More
Centre for Ocular Research & Education (CORE)

CORE Names Its “Top 10 of 2024” Scientific Papers

CORE reveals its Top 10 scientific papers of 2024, covering innovations in drug-releasing lenses, myopia control, scleral lenses for dry eye, and global contact lens trends. See the full list online.

Read More
March-April Optik 2025 Sustainability in Sight article

Sustainability in Sight: Green Frames, Lenses, and Best Practices

From Italy to Canada, discover the brands making sustainability more than a trend in eyewear—from renewable acetate to zero-waste contact lens programs.

Read More
Voila March-April Optik 2025 AYA CETANGI

Buffalo Spirit Meets Modern Vision: AYA Optical x Lakota Artist Yellowhawk

AYA Optical proudly introduces Cetangi, the latest eyewear style featuring Jim Yellowhawk’s White Buffalo design.

Read More
CooperVision

Innovative Sustainability Partnership Celebrates Far-Reaching Impacts on People + Planet

The multi-continent program—in collaboration with Plastic Bank®, eye care professionals, and contact lens wearers—has now prevented the equivalent of more than half a billion plastic bottles from entering the world’s oceans.

Learn More
CSI Dry eye software

CSI Dry Eye Software Announces Ken Barbet as New Chief Executive Officer

CSI Dry Eye Software, the first-of-its-kind dry eye management platform powered by artificial intelligence (AI), machine learning, and data science, announces the appointment of Ken Barbet as its new Chief Executive Officer (CEO).

Read more
Centre for Ocular Research & Education (CORE)

CORE Names Its “Top 10 of 2024” Scientific Papers

CORE reveals its Top 10 scientific papers of 2024, covering innovations in drug-releasing lenses, myopia control, scleral lenses for dry eye, and global contact lens trends. See the full list online.

Read more
March-April Optik 2025 Sustainability in Sight article

Sustainability in Sight: Green Frames, Lenses, and Best Practices

From Italy to Canada, discover the brands making sustainability more than a trend in eyewear—from renewable acetate to zero-waste contact lens programs.

Read more
Voila March-April Optik 2025 AYA CETANGI

Buffalo Spirit Meets Modern Vision: AYA Optical x Lakota Artist Yellowhawk

AYA Optical proudly introduces Cetangi, the latest eyewear style featuring Jim Yellowhawk’s White Buffalo design.

Read more
CooperVision

Innovative Sustainability Partnership Celebrates Far-Reaching Impacts on People + Planet

The multi-continent program—in collaboration with Plastic Bank®, eye care professionals, and contact lens wearers—has now prevented the equivalent of more than half a billion plastic bottles from entering the world’s oceans.

Learn More
CSI Dry eye software

CSI Dry Eye Software Announces Ken Barbet as New Chief Executive Officer

CSI Dry Eye Software, the first-of-its-kind dry eye management platform powered by artificial intelligence (AI), machine learning, and data science, announces the appointment of Ken Barbet as its new Chief Executive Officer (CEO).

Read more
Centre for Ocular Research & Education (CORE)

CORE Names Its “Top 10 of 2024” Scientific Papers

CORE reveals its Top 10 scientific papers of 2024, covering innovations in drug-releasing lenses, myopia control, scleral lenses for dry eye, and global contact lens trends. See the full list online.

Read more
March-April Optik 2025 Sustainability in Sight article

Sustainability in Sight: Green Frames, Lenses, and Best Practices

From Italy to Canada, discover the brands making sustainability more than a trend in eyewear—from renewable acetate to zero-waste contact lens programs.

Read more
Voila March-April Optik 2025 AYA CETANGI

Buffalo Spirit Meets Modern Vision: AYA Optical x Lakota Artist Yellowhawk

AYA Optical proudly introduces Cetangi, the latest eyewear style featuring Jim Yellowhawk’s White Buffalo design.

Read more